What's new in caMOD - September 2010
The following models have recently been approved for public display. Visit http://cancermodels.nci.nih.gov to learn more about these new models.
| caMOD ID |
Model Descriptor |
Species |
|---|---|---|
| 150065424 | Bronchial and Peripheral Murine Lung Carcinomas Induced by T790M-L858R Mutant EGFR Respond to HKI-272 and Rapamycin Combination Therapy | Mouse |
| 150065641 | Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. | Mouse |
| 150065617 | Rapamycin suppresses tumorigenesis in a mouse model of progressive bladder cancer | Mouse |
| 150065531 | Effective use of PI3K and MEK inhibitors to treat mutant tet-op-Kras G12D murine lung cancers | Mouse |
| 150065511 | Effective use of PI3K and MEK inhibitors to treat mutant PIK3CA H1047R murine lung cancers | Mouse |
| 150065690 | Effective use of PI3K and MEK inhibitors to treat mutant LSL Kras G12D murine lung cancers | Mouse |
| 150065805 | Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis in MMTV-D1T286A mice | Mouse |
| 150065815 | Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis in MMTV-D1 mice | Mouse |
| 150065849 | TßRII(fl/fl);PY;WC | Mouse |
| 150065853 | TßRII(fl/fl);PY;MC | Mouse |
| 150065736 | NRL-PRL MMTV-Cre Jak2fl/fl | Mouse |
| 150065714 | Prolactin induces ERaa-positive and ERa-negative mammary cancer in Tg(Nrl-Prl)24Eps transgenic mice | Mouse |
| 150065711 | Prolactin induces ERa-positive and ERa-negative mammary cancer in Tg(Nrl-Prl)23Eps transgenic mice | Mouse |
| 150065254 | Tg(Sprr2f-cre)1Dcas x Lkb1L | Mouse |
| 150065280 | Lkb1fl excised in the uterus leads to endometrial cancer | Mouse |
| 150065298 | Lkb1-/+ - involvement in endometrial cancer | Mouse |
| 50057351 | Nf1+/-KRas* | Mouse |
| 50057313 | Nf1+/-GFAPCKO | Mouse |
| 50057345 | Nf1+/-GFAP-mCKO | Mouse |